To provide a direct path towards a more effective translation of IL-24 therapy from laboratory trials to clinical application, it is of fundamental importance to either increase the overall administration of local IL-24 or facilitate its specific delivery to the tumor’s location (72). This evidence concerns the gene IL24 and neoplasm.